BioTech experience . One such initiative is our Data Technology Centre that was established in 2019 and serves as a global hub for our team to use digital technologies and platforms to enhance product R & D and global operations .
How do you see the life sciences industry evolving in India , and how is the company positioning itself to adapt to these changes ?
According to Grandview Research , globally , the biotechnology and biopharma sectors are growing rapidly , with an expected compound annual growth rate of 10.3 % from 2023 to 2030 . This is highly positive for the industry as this means that the popularity of biosimilars will continue to rise , with more interest and investment , thereby opening more opportunities like funding and developments for the sector .
For Indian companies serving Indian and regional customers and patients , it is even more crucial to ensure that India maintains its stronghold in generics and that we can keep up with
BIOVOICENEWS . COM 61